(BTI) British American Tobacco - Ratings and Ratios

Exchange: NYSE • Country: United Kingdom • Currency: USD • Type: Common Stock • ISIN: US1104481072

BTI: Cigarettes, Vaping Products, Oral Nicotine

British American Tobacco p.l.c. (NYSE:BTI) is a global leader in the tobacco and nicotine products industry, operating across the Americas, Europe, Asia-Pacific, the Middle East, Africa, and the United States. The company offers a diverse portfolio of products, including vapour devices, heated tobacco products, modern oral nicotine solutions, combustible cigarettes, and traditional oral products such as snus and moist snuff. Its brand portfolio includes Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel. These products are distributed to a wide network of retail outlets globally. Established in 1902 and headquartered in London, the company has a long history of innovation and market presence in the tobacco industry.

From a technical perspective, BTI is currently trading at $42.37, with a 20-day average volume of 5,227,594 shares. The stock has shown upward momentum, with its SMA 20 at $40.78, SMA 50 at $40.00, and SMA 200 at $36.04, indicating a rising trend. The ATR of 0.83 reflects moderate volatility. On the fundamental side, the company has a market cap of $91.17 billion, with a trailing P/E of 22.39 and a forward P/E of 8.48, suggesting potential undervaluation. The P/B ratio of 1.35 and P/S ratio of 3.52 indicate a relatively stable financial position, though the negative RoE of -38.37 raises concerns about profitability.

Based on and , British American Tobacco p.l.c. is expected to trade in the range of $40.50 to $44.50 over the next three months. The stock may face resistance near the $44.00 level, with support likely at $40.00. The ATR of 0.83 suggests moderate price fluctuations, while the upward trend in SMA indicators points to potential bullish momentum. However, the negative RoE and high trailing P/E may limit upside potential.

Additional Sources for BTI Stock

BTI Stock Overview

Market Cap in USD 92,953m
Sector Consumer Defensive
Industry Tobacco
GiC Sub-Industry Tobacco
IPO / Inception 1980-04-14

BTI Stock Ratings

Growth Rating 59.4
Fundamental 40.8
Dividend Rating 79.0
Rel. Strength 42.7
Analysts 3/5
Fair Price Momentum 50.38 USD
Fair Price DCF 168.28 USD

BTI Dividends

Dividend Yield 12m 13.46%
Yield on Cost 5y 20.63%
Annual Growth 5y 1.88%
Payout Consistency 88.9%

BTI Growth Ratios

Growth Correlation 3m 62.2%
Growth Correlation 12m 92.1%
Growth Correlation 5y 60.6%
CAGR 5y 10.87%
CAGR/Max DD 5y 0.36
Sharpe Ratio 12m 2.75
Alpha 51.91
Beta 0.035
Volatility 20.26%
Current Volume 4374.4k
Average Volume 20d 6011.2k
What is the price of BTI stocks?
As of April 25, 2025, the stock is trading at USD 42.45 with a total of 4,374,367 shares traded.
Over the past week, the price has changed by +0.19%, over one month by +5.87%, over three months by +14.05% and over the past year by +56.30%.
Is British American Tobacco a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, British American Tobacco (NYSE:BTI) is currently (April 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 40.81 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BTI as of April 2025 is 50.38. This means that BTI is currently undervalued and has a potential upside of +18.68% (Margin of Safety).
Is BTI a buy, sell or hold?
British American Tobacco has received a consensus analysts rating of 3.00. Therefor, it is recommend to hold BTI.
  • Strong Buy: 0
  • Buy: 2
  • Hold: 1
  • Sell: 0
  • Strong Sell: 1
What are the forecast for BTI stock price target?
According to ValueRays Forecast Model, BTI British American Tobacco will be worth about 54.4 in April 2026. The stock is currently trading at 42.45. This means that the stock has a potential upside of +28.17%.
Issuer Forecast Upside
Wallstreet Target Price 44.5 4.9%
Analysts Target Price 44.5 4.9%
ValueRay Target Price 54.4 28.2%